SNDX vs TARS Stock Comparison
TARS currently leads SNDX in this stock comparison, with AIQ scores of 65 vs 43. The clearest difference is momentum, while SNDX has the stronger quality profile.
What is the main difference between SNDX and TARS?
TARS leads the current stock comparison as Tarsus Pharmaceuticals, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Syndax Pharmaceuticals, Inc. vs Tarsus Pharmaceuticals, Inc.
TARS leads
TARS leads by 22 AIQ points, primarily on Momentum and Risk Resilience, but the lead has narrowed from 27 points over 30 sessions. Wall Street currently favors SNDX on target upside.
Competitive: 4 of 6 evidence groups support TARS, its lead is narrowing, and its current signal state is conflicted.
Syndax Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors TARS over SNDX, 65 versus 43 as of Nov 15, 2026. TARS's advantage is driven primarily by stronger momentum and risk resilience, while SNDX holds the stronger quality profile. TARS also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors SNDX. 4 of 6 covered evidence groups favor TARS today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. TARS lead: Weakening — the AIQ differential moved from 27 to 22 points over 30 sessions.
Compare Syndax Pharmaceuticals, Inc. and Tarsus Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare SNDX and TARS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum14 vs 76TARS +62
- Risk Resilience37 vs 59TARS +22
- Quality66 vs 50SNDX +16
- Value64 vs 75TARS +11
4 of 6 evidence groups favor TARS. TARS’s edge is concentrated in momentum and risk resilience; SNDX keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +2
No signal started or stopped since the prior session; its 7 active signals are unchanged.
Largest factor move: Value +2
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
TARS's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — SNDX and TARS both carry a full feed there.
The central trade-off
TARS (Tarsus Pharmaceuticals, Inc.): the stronger current systematic profile, led by momentum and risk resilience.
SNDX (Syndax Pharmaceuticals, Inc.): the counter-case, on quality, fundamentals, analyst expectations — but at materially higher volatility, 113.3% against 44.7%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TARSTARS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
SNDXSNDX on combined revenue and EPS growth.
Value
TARSTARS on the peer-relative Value factor, by 11 points.
Momentum
TARSTARS on the Momentum factor, by 62 points.
Lower downside
TARSTARS on Risk Resilience, by 22 points.
Analyst upside
SNDXSNDX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors TARS, analyst targets favor SNDX. That disagreement is the most useful thing on this page.
| Measure | SNDX | TARS | Note |
|---|---|---|---|
| Implied upside to target | +288.9% | +36.1% | SNDX has more room |
| Target dispersion | +27.2% | +10.1% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 12 | 10 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor TARS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | TARS | 43 vs 65 |
| Fundamentals | SNDX | revenue growth 14.4% vs 11.9%; TTM ROE 287.7% vs -6.4%; gross margin 93.7% vs 93.2%; operating margin -61.7% vs -102% |
| Valuation | TARS | Value 64 vs 75 |
| Technicals | TARS | Price vs 50-day -38.1% vs 7.3%; vs 200-day -52.1% vs 18.1% |
| Risk Resilience | TARS | Risk Resilience 37 vs 59 |
| Analyst expectations | SNDX | Target upside 288.9% vs 36.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of SNDX and TARS and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 22 points. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TARS.
How the comparison changed
120 daily snapshots · May 27 – Nov 13TARS lead: Weakening — the AIQ differential moved from 27 to 22 points over 30 sessions.
- Today
- TARS +22
- 43 vs 65
- 7 sessions ago
- TARS +22
- 44 vs 66
- 30 sessions ago
- TARS +27
- 43 vs 70
- 90 sessions ago
- TARS +13
- 53 vs 66
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 4 bearish / 2 neutral, conflicted
Only SNDX
- Death Cross Active — bearish, trend, long horizon (29.12%)
- 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold — bullish, momentum, short horizon
5 bullish / 1 bearish / 1 neutral, conflicted
Only TARS
- Golden Cross Active — bullish, trend, long horizon (10.12%)
- BB Upper Band Breach — bearish, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
TARS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.94%, AIQ +1 points).
Price and the AIQ Score both moved up over the latest session (price +4.41%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1SNDX closes the Momentum gap — currently 62 points behind, the largest single contributor to TARS's edge.
- 2SNDX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3TARS's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 22-point move would eliminate TARS's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
SNDX leads on balance| Metric | SNDX | TARS |
|---|---|---|
| Revenue growth (YoY) | 14.4% | 11.9% |
| EPS growth (YoY) | 0% | -32.5% |
| Gross margin | 93.7% | 93.2% |
| Operating margin | -61.7% | -102% |
| Return on equity (TTM) | 287.7% | -6.4% |
| Debt to equity | -34.31 | 0.85 |
Performance
TARS leads 6 of 6 windows| Metric | SNDX | TARS |
|---|---|---|
| 1 week (5 sessions) | -0.9% | 17% |
| 1 month (20 sessions) | -26.7% | 17.9% |
| 3 months (63 sessions) | -52.2% | 13.7% |
| 6 months (126 sessions) | -53.3% | 28.5% |
| Year to date | -55% | -2% |
| 1 year (252 sessions) | -43.7% | 7.3% |
Technicals
TARS has the stronger structure| Metric | SNDX | TARS |
|---|---|---|
| RSI (14) | 26.2 | 64.8 |
| ADX (14) | 47.7 | 16.7 |
| Price vs 50-day | -38.1% | 7.3% |
| Price vs 200-day | -52.1% | 18.1% |
| Volatility (1M, annualized) | 113.3% | 44.7% |
Risk
TARS is the more resilient| Metric | SNDX | TARS |
|---|---|---|
| Beta | 0.77 | 0.56 |
| Sharpe ratio | -0.76 | 0.36 |
| Sortino ratio | -0.97 | 0.55 |
| Max drawdown | -62.7% | -32% |
| Current drawdown | -62.4% | -11.6% |
| Annualized volatility | 57.2% | 45% |
| Value at risk (95%) | -4.5% | -4.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, SNDX or TARS?
On the Algovestiq AIQ Score, TARS is the stronger of the two as of Nov 15, 2026, scoring 65 against SNDX's 43. The edge comes from momentum and risk resilience. SNDX is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is SNDX or TARS the better buy right now?
TARS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor TARS over SNDX?
The composite weights Quality, Value, Momentum and Risk Resilience. TARS leads Momentum by 62 points; TARS leads Risk Resilience by 22 points; SNDX leads Quality by 16 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, SNDX or TARS?
Analyst price targets imply +288.9% upside for SNDX and +36.1% for TARS, so the Street currently favors SNDX. That points the opposite way to the AIQ Score, which favors TARS. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, SNDX or TARS?
TARS is the better-valued of the two on the peer-relative Value factor. TARS on the peer-relative Value factor, by 11 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, SNDX or TARS?
SNDX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, SNDX or TARS?
TARS on the Momentum factor, by 62 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, SNDX or TARS?
TARS is the more resilient of the two, so the other name carries the higher downside risk. TARS on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is SNDX more profitable than TARS?
SNDX leads on the comparable margin measures — gross margin 93.7% vs 93.2%; operating margin -61.7% vs -102%; ttm roe 287.7% vs -6.4%.
Is TARS's lead over SNDX getting stronger or weaker?
TARS lead: Weakening — the AIQ differential moved from 27 to 22 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the SNDX vs TARS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SNDX closes the Momentum gap — currently 62 points behind, the largest single contributor to TARS's edge; SNDX's Death Cross Active resolves — a bearish trend rule currently active against it; TARS's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 22-point move would eliminate TARS's advantage entirely.
What do the current signals say about SNDX and TARS?
SNDX: 1 bullish / 4 bearish / 2 neutral, conflicted. TARS: 5 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on SNDX is Death Cross Active (bearish, long horizon). On TARS it is Golden Cross Active (bullish, long horizon).
Compare SNDX and TARS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.